Factory Mutual Insurance’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-408,597
Closed -$9.96M 130
2021
Q2
$9.96M Sell
408,597
-5,130
-1% -$116K 0.12% 121
2021
Q1
$10.7M Buy
413,727
+117,577
+40% +$5.18M 0.14% 123
2020
Q4
$15.8M Buy
296,150
+143,150
+94% +$7.11M 0.21% 109
2020
Q3
$6.31M Buy
+153,000
New +$6.61M 0.1% 106

Other funds holding ACAD

Factory Mutual Insurance's ACAD Position: Q3 2021 in Review

Factory Mutual Insurance sold out of Acadia Pharmaceuticals (ACAD) in Q3 2021, closing a stake of 408,597 shares — an estimated $9.96M sold.

Factory Mutual Insurance first reported a position in ACAD in Q3 2020 and held it in 4 quarters. The position peaked at $15.8M in Q4 2020. 237 funds tracked by Wall St. Rank hold ACAD as of Q3 2021.

  • Factory Mutual Insurance reported no remaining Acadia Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Factory Mutual Insurance sold 408,597 Acadia Pharmaceuticals shares in Q3 2021, an estimated $9.96M.
  • Factory Mutual Insurance first reported a position in Acadia Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Factory Mutual Insurance's Acadia Pharmaceuticals position peaked at $15.8M in Q4 2020.
  • 237 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q3 2021.

Based on Factory Mutual Insurance's 13F filing for Q3 2021, filed 12 Nov 2021.